"Over night the shares went up +/- 700% and then continued to go up a little from there. The point is the market cap of TBRA on the market was dramatically less than what Allergan was willing to pay which is where my thought is on both RVX and what many think Zenith is worth today."

You can't value Zenith TODAY based on what some company MIGHT be willing to pay for it somewhere down the road.  You'll find out what Zenith is worth at the next financing. 

Same with RVX.  You can't fantasize what some company MIGHT be willing to pay for RVX, YEARS from now, IF the Phase III is successful and conclude THAT's what it's worth TODAY.  RVX TODAY is worth 2.10 a share.  Not a penny more.